Related Experiment Video
Updated: Jan 15, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Utility of CHA2DS2-VASc Score in Predicting Contrast-induced Nephropathy in Patients with Acute Myocardial Infarction
Ramya R Bhat1, Ashwin Kulkarni2, Anupama V Hegde3
1Junior Resident, Department of General Medicine, Ramaiah Medical College, Bengaluru, Karnataka, India.
Insights
The CHA2DS2-VASc score can predict contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). A score greater than 2 indicates a higher risk of developing CIN, aiding in risk stratification for this kidney impairment.
Area of Science:
- Nephrology
- Cardiology
- Interventional Cardiology
Background:
- Contrast-induced nephropathy (CIN) is a kidney impairment following contrast agent injection.
- Patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) are at risk for CIN.
- Current methods for predicting CIN lack high accuracy.
Purpose of the Study:
- To validate the CHA2DS2-VASc score for predicting CIN in patients undergoing PCI.
- To assess the predictive capability of the CHA2DS2-VASc score in this patient population.
Main Methods:
- A cross-sectional study of 182 patients with ACS undergoing PCI.
- Calculation of CHA2DS2-VASc scores for all patients.
- Receiver operating characteristic (ROC) curve analysis to determine optimal cutoff values for predicting CIN.
Main Results:
- The incidence of CIN was 14.3%.
- The CHA2DS2-VASc score demonstrated a high predictive value (ROC value = 0.896).
- A CHA2DS2-VASc score >2 was associated with a statistically significant increase in CIN incidence.
Conclusions:
- The CHA2DS2-VASc score is a valuable tool for predicting contrast nephropathy in patients with acute myocardial infarction undergoing angiography.
- Elevated CHA2DS2-VASc scores (>2) identify patients at higher risk for CIN post-PCI.
Background:
Contrast-induced nephropathy (CIN) is an iatrogenic impairment to the kidneys that can occur in susceptible persons after intravascular injections of contrast agents. Individuals undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) often bear the risk of developing CIN. The likelihood of CIN can be predicted using several techniques, although none of them are very accurate. CHA2DS2-VASc score is used to predict unfavorable clinical outcomes in patients with ACS and atrial fibrillation. The score comprises preprocedural variables and is simple to calculate and can be used for predicting CIN. This study aims to validate CHA2DS2-VASc score to predict occurrence of CIN among patients undergoing PCI.
Materials And Methods:
This cross-sectional research has been carried out at a tertiary care hospital. The study comprised a total of 182 patients who were admitted with ACS and underwent PCI. CIN incidence was computed. The study population was divided into two groups (the CIN group and the non-CIN group) based on the incidence of CIN. The CHA2DS2-VASc score was computed for every patient. The best cutoff values of the CHA2DS2-VASc score to predict the development of CIN were found using receiver operating characteristic (ROC) curve analysis. The incidence of CIN was computed both above and below the CHA2DS2-VASc score's optimal cutoff point.
Results:
The incidence of CIN among patients undergoing PCI was 14.3%, and the ROC value for the CHA2DS2-VASc score was 0.896. Statistically significant increases in the incidence of CIN were observed in patients undergoing PCI who had a CHA2DS2-VASc score of >2. Additionally, a significant relationship was discovered between CIN and age, diabetes, hypertension, prior coronary artery disease (CAD), and Killip class ≥2.
Conclusion:
Patients with CHA2DS2-VASc score of >2 had higher incidence of CIN. CHA2DS2-VASc score was found to be useful in predicting contrast nephropathy among patients with acute myocardial infarction undergoing angiography.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT